Dec 21 2011
Here is a December 19 “FirstWord” post announcing EU clearance of rivaroxaban (Xarelto, Bayer) for stroke prevention and treatment of deep venous thrombosis. Thanks to Steve Duff, Precision BioLogic co-CEO for alerting me to this evidence of the 2011 march to the adoption of new oral anticoagulants.
Comments (0)Anticoagulant Therapy
No comments here.